Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MBX.TO Relative to the S&P 500

MBX.TO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Microbix Biosystems, Inc. (TSE:MBX.TO) seasonal charts above shows that a Buy Date of December 17 and a Sell Date of March 7 has resulted in a geometric average return of 10.24% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 21.31% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company’s operating segment includes Antigen and QAPs and Other. It generates maximum revenue from the Antigen and QAPs segment. Geographically, it derives a majority of revenue from North America.

To download MBX.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MBX.TO